drug development - International Biopharmaceutical Industry

news

Abingworth ‘Will Launch $1.5bn Fund for Co-developed Drugs’

Venture capital group Abingworth is reportedly trying to raise up to $1.5 billion in investment funding to support biopharma companies' clinical development programm...

2 December 2024 news Abingworth | biopharma

Continue Reading →

Volume 4 Issue 4

How Involved Should Biopharma CEOs Be In Outsourcing Activities?

When outsourcing drug development and manufacturing, how involved should the CEOs of emerging biopharma be in the requisite day-to-day activities and processes? Louis...

9 December 2021 Volume 4 Issue 4 Aristea Therapeutics | biopharma

Continue Reading →

news

SGS Increases Biosafety Testing Capacity at Its Glasgow Facility

SGS has just completed a significant expansion project at its Glasgow facility, meaning it can provide increased biosafety testing for the biologics, drug development...

28 October 2021 news biological medicines | cell therapy

Continue Reading →

news

Galapagos CEO to retire, though successor yet to be announced

Galapagos looked to be in a strong position at the start of 2020. It had recently closed a major research deal with Gilead that not only provided substantial amounts ...

3 September 2021 news drug development | FDA

Continue Reading →

news

Lilly’s new eczema drug scores in late-stage studies

Once known primarily for its work in diabetes, Lilly has, for years now, been branching into other areas of drug development like immunology. There, the company has ...

20 August 2021 news arthritis | diabetes

Continue Reading →